Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
Por um escritor misterioso
Descrição
PDF) Class switch towards spike protein-specific IgG4 antibodies after SARS- CoV-2 mRNA vaccination depends on prior infection history
Exploration of factors correlated with Long COVID
Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history
The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees - eBioMedicine
Frontiers Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies
Non-neutralizing functions in anti-SARS-CoV-2 IgG antibodies - ScienceDirect
Frontiers mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals, BMC Medicine
Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals, BMC Medicine
Frontiers mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
3rd Pfizer Vaccine Shot Increases Non-inflammatory IgG4
PDF) Class switch towards spike protein-specific IgG4 antibodies after SARS- CoV-2 mRNA vaccination depends on prior infection history
Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients, BMC Medicine
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)